Chris Lau

Chris Lau

InvestorPlace Contributor

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

OPKO Stock Had a Great Q2 and the Future Looks Even Better

By Chris Lau, InvestorPlace Contributor

With shares nearly double where they were in May, OPKO Health, Inc. (NASDAQ:OPK) needed a strong second-quarter earnings report to justify the gains in OPKO…

After the Dip, Symantec Stock Could Have at Least 30% Upside

By Chris Lau, InvestorPlace Contributor

Symantec missed analyst forecasts and lowered its current second quarter outlook. Business will underperform for the rest of the fiscal year, but things look brighter for SYMC stock by fiscal year 2020.

Mazor Robotics Is Still Expensive Despite Recent Drop

By Chris Lau, InvestorPlace Contributor

Investors expected more from Mazor Robotics and the company failed to deliver. The Medtronic distribution deal is to blame. Will business improve?

All the Good News (And Then Some) Already Is Priced into Abiomed Stock

By Chris Lau, InvestorPlace Contributor

Abiomed stock is down 10 percent following first-quarter earnings. The company exceeded expectations and reported growth in the triple digits. So what gives? The good news is priced in.

Why Every Investor Should Hold Shares of Biogen Stock

By Chris Lau, InvestorPlace Contributor

Biogen reported solid study results for its Alzheimer's study and followed up with a solid quarterly earnings report. BIIB stock is a clear core holding for investors.

Load More